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proteins are remarkably stable and resistant to most conven-
tional sterilisation measures.5 Iatrogenic transmission of human
prion diseases via neurosurgical instruments has been reported6
and there is some evidence that transmission via other surgical
procedures may also occur.7
The potential risk of transmission of CJD in dentistry is unclear.
Animal models have demonstrated the possibility of transmission
of prions via the oral route,8–10 but current epidemiological evi-
dence largely excludes a correlation between dental surgery and
CJD.7,11,12 However, small clusters of CJD cases possibly con-
nected by dental procedures have been reported.6,13 Whilst a
recent paper has been unable to detect prion protein in dental
pulp from patients with sporadic CJD,14 vCJD differs from the
sporadic, iatrogenic and familial forms, in that the lymphoreticu-
lar tissues of vCJD cases are consistently infected with prion pro-
teins.15 Further work is required to determine the infectivity of
human pulpal and gingival tissues.
A Fact File,16 based on current recommendations from the
Spongiform Encephalopathy Advisory Committee (SEAC), has
been issued by the BDA. This recommends using the medical
history form to identify patients who may be at risk of iatrogenic
or familial forms of CJD. Questions enquire about previous
Cross infection control measures and 
the treatment of patients at risk of
Creutzfeldt Jakob Disease in UK general
dental practice
J. Bagg,1 C. P. Sweeney,2 K. M. Roy,3 T. Sharp,4 and A. Smith,5
Aims To determine the suitability of key infection control
measures currently employed in UK dental practice for delivery
of dental care to patients at risk of prion diseases.
Materials and methods Subjects: Five hundred dental surgeons
currently registered with the General Dental Council of the UK.
Data collection: Structured postal questionnaire. Analysis:
Frequencies, cross-tabulations and chi-squared analysis.
Results The valid response rate to the questionnaire was 69%.
33% of practices had no policy on general disinfection and
sterilisation procedures. Only 10 of the 327 responding practices
(3%) possessed a vacuum autoclave. 49% of dentists reported
using the BDA medical history form but less than 25% asked the
specific questions recommended by the BDA to identify patients
at risk of iatrogenic or familial CJD. However, 63% of
practitioners would refer such patients, if identified, to a
secondary care facility. Of the 107 practitioners who were
prepared to provide dental treatment, 75 (70%) would do so
using routine infection control procedures.
Conclusions Most of the dental practices surveyed were not
actively seeking to identify patients at risk of prion diseases. In
many cases, recommended procedures for providing safe dental
care for such patients were not in place.
The transmissible, spongiform encephalopathies (TSEs) com-prise a group of neurodegenerative disorders caused by
infection with prions.1 This group of diseases includes sporadic,
familial and iatrogenic forms of Creutzfeldt Jakob Disease
(CJD).1 These diseases are very rare. For example, UK Depart-
ment of Health statistics for the year 2000 report 42 cases of spo-
radic CJD, one of iatrogenic CJD and two cases of familial CJD.
The description of a new form of CJD,2 now termed variant CJD
(vCJD), together with evidence that it is caused by the same
agent as bovine spongiform encephalopathy (BSE),3,4 has signif-
icantly raised the profile of the TSEs. It has also caused serious
concerns in relation to infection control procedures, since prion
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Fig. 1 The methods employed by practitioners for the cleaning of
dental instruments prior to sterilisation
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brain surgery (in order to identify possible recipients of dura
mater grafts); growth hormone use before the mid-1980s (after
which artificially synthesised growth hormone came into use);
and close family members who might have had CJD (to identify
those at risk of familial CJD).16 These questions will not, how-
ever, identify those at risk of sporadic or vCJD. Patients who are
identified as being at risk should either be treated with dispos-
able instruments which are subsequently incinerated, or non-
disposable instruments which should pass through a stringent
decontamination process, separately from other instruments.
This involves two washing cycles and a total of 18 minutes in a
porous load (vacuum) autoclave.16 These recommended proce-
dures represent significant changes to infection control practices
for dental surgeons. 
The present study had three aims. The first was to determine the
proportion of dental practitioners who were using the recom-
mended questions in the BDA Medical History Form. The second
was to assess whether the decontamination and sterilisation pro-
cedures currently used in general dental practice would satisfy the
criteria laid down by the SEAC. The final aim was to examine the
willingness of dental surgeons to treat those at risk of CJD.
Materials and method
Study participants
Five hundred dental surgeons were selected at random from those
registered in the United Kingdom with the General Dental Council
(GDC). The names and addresses of these practitioners were then
downloaded from the GDC web site.
Questionnaire
The questionnaire was divided into three sections. The first 
collected demographic data including sex, age band and sphere of
dental practice (general dental practitioner, community dental
practitioner or hospital/university dental service). 
The second section related to decontamination and sterilisation
procedures. The questions inquired if there was a written disinfec-
tion and sterilisation policy for the surgery or clinic; whether
matrix bands, steel burs, endodontic instruments, mouthwash
beakers, aspirator tips and scalpels were viewed as single use items;
the methods used for cleaning instruments prior to sterilisation;
the type and age of autoclave(s) used; and finally, the frequency of
testing of autoclaves. No details were sought on the methods used
for autoclave testing.
The third section sought information on whether practitioners used
the BDA recommended questions in their Medical History Form to
identify those at risk of CJD, and how frequently the medical histories
of regular patients were updated. Finally, the practitioners were asked
whether they would be prepared to treat patients at risk of CJD and, if
so, what precautions they would take to prevent transmission.
The survey
The questionnaires were sent out in June 2000. A detailed covering
letter, which explained the background to the study and stressed
that the survey was completely anonymous, accompanied each
questionnaire. A reply paid envelope was enclosed for return of the
completed questionnaire. Reminder letters, containing a further
copy of the questionnaire and another reply-paid envelope, were
mailed in August 2000.
Data analysis
Data were analysed using SPSS (Statistical Package for the Social
Sciences). A database was established in SPSS. Frequencies were
used to examine the distribution of responses for all the vari-
ables and to describe sample demographics. The association
between variables was examined by cross-tabulations and the
statistical significance of such relationships examined by chi-
squared analysis.
Results
Respondents 
Two of the 500 questionnaires were returned by the Post Office as
undelivered. A total of 327 returned questionnaires were useable. A
further 26 practitioners returned questionnaires indicating that
they had retired from dentistry, and four questionnaires were
returned blank. This represents an overall valid response rate of
327/472 (69%).
Of those providing useable responses, 236 (73%) were male. The
age distribution was 55 (17%) 21–30 years; 112 (34%) 31–40 years;
102 (31%) 41–50 years, 45 (14%) 51–60 years and 13 (4%) more
than 60 years old. The group comprised 280 (86%) general dental
practitioners, 29 (9%) community dental surgeons and 15 (5%)
hospital/university dentists. 
Chi-squared analyses showed no effects of age or sex on the para-
meters reported below.
Sterilisation and disinfection practices
Of those responding, 217 (67%) had a written policy detailing the
disinfection and sterilisation procedures to be followed. Of those
for whom no such policy was available, 98% were in general den-
tal practice.
The majority of respondents re-processed matrix bands (88%),
steel burs (75%) and endodontic instruments (88%) after use. Dis-
posable aspirator tips were used by 59% and the majority used dis-
posable mouthwash beakers (96%) and scalpels (97%).
The frequency of use of the various methods for cleaning
instruments prior to sterilisation is shown in Figure 1. Whilst a
wide range of combinations were employed, hand brushing was
an element of the cleaning reported by 297 (91%) of those
responding.
The age of the autoclaves in the practices varied from brand new
to 28 years old (mean 6.8 ± 5.1 years). Ten of the 327 responding
practices (3%) possessed a vacuum autoclave. Figure 2 illustrates
Fig. 2 The frequency of testing of autoclaves in the dental practices
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the frequency of autoclave testing undertaken. Only a small propor-
tion of practitioners (2%) undertook no checks whatsoever and
49% had a commercial maintenance contract.
Medical history form
The Medical History Form, recommended by the BDA in 1998, was
reportedly used by 49% of the respondents. However, only a minor-
ity of dentists used the specific questions related to identifying those
at risk of iatrogenic and familial CJD. Thus, 24% enquired about
previous brain surgery, 20% asked about treatment with growth
hormone and 18% asked patients whether they had a close relative
with CJD. More than three-quarters of respondents (79%) had a
policy of updating medical histories at least annually (Fig. 3).
As far as management of a patient identified to be at risk of
CJD was concerned, a high proportion (63%) would refer the
case to a secondary care facility (Fig. 4). Of the 107 (33%) practi-
tioners who were prepared to provide dental treatment, 75
(70%) would do so using routine infection control procedures,
while 32 (30%) would incinerate the dental equipment used
(Figure 4). Of the latter, 11 practitioners would then refer the
patient on for continuation of care. 
Discussion
The discovery of variant CJD,2 together with widespread scientific
and media interest in this disease, have heightened awareness of
the risk of transmission of prions in the healthcare setting. The
number of cases of vCJD in the UK is still low (95 definite and
probable cases to 2 March 2001), and a preliminary screening
study of vCJD reactivity in around 3000 archived tonsils and
appendix specimens revealed no positive results.17 However, there
is still concern among many experts that an epidemic, linked to
consumption of meat from BSE-infected herds, may develop.18 It
is, therefore, important that the dental profession gives serious
thought to provision of safe dental care, in the light of the resis-
tance of prions to traditional sterilisation procedures.5 The find-
ings of the present study suggest that general dental practice is not
currently equipped to address some of these issues. 
It is of concern that 33% of respondents had no practice policy on
disinfection and sterilisation procedures. Irrespective of the CJD
problem, dental practices must show a commitment to decontami-
nation and sterilisation; a written policy, understood by all the den-
tal team is viewed as a pre-requisite. 
Most of the practices reprocessed steel burs, matrix bands and
endodontic instruments and the majority cited cleaning fol-
lowed by autoclaving as their routine decontamination proce-
dure. This is a logical process, but it must be remembered that
these items are difficult to clean because of their complex sur-
face contours. In relation to sterilisation in general, but prion
decontamination in particular, initial cleaning is an essential
stage of instrument reprocessing19 and great care must be taken
to perform the cleaning thoroughly. Many combinations of
methods were reported for the cleaning of instruments, but
most (91%) of these involved an element of hand scrubbing. In
a recent study of matrix band cleaning (submitted for publica-
tion) ultrasonic baths were significantly more effective than
hand scrubbing for removal of blood contamination. It is also
important that dental nurses are aware of the need for strong
gloves and to take care to avoid sharps injuries during hand
cleaning of instruments.
Ten practices had access to a vacuum autoclave, whilst all the
remaining practices used downward displacement autoclaves.
Although acceptable for the routine sterilisation of unwrapped
instruments, downward displacement autoclaves are not deemed
appropriate for inactivation of prions.16 Thus, for the vast major-
ity of dental practices in the UK, any instruments used in the
treatment of patients at risk of CJD would have to be incinerated.
Practitioners replacing old autoclaves should consider purchase
of a vacuum model.
The questionnaire did not identify whether or not respondents
were BDA members. However, the survey indicated that a high pro-
portion of UK dentists were not making use of the new BDA recom-
mended medical history form (released 1998). The form contains
three questions designed to identify patients at risk of iatrogenic or
familial CJD. In reality, it appears that few dentists ask these specific
questions, even if they are using a BDA recommended medical 
history form, though many believed that the more general questions
they used would identify those who had undergone brain surgery or
received growth hormone injections. Most of the practitioners
updated patients’ medical histories at least annually, but since few
are actively seeking out patients in the ‘at risk’ group, it is unlikely
that large numbers will be identified in dental practice. Neverthe-
less, more than 60% of dentists indicated that if such patients were
identified, they would refer them to a secondary care facility, as cur-
rently recommended in the BDA Fact File.16 Of those prepared to
provide treatment for such patients in the practice, 70% would use
routine infection control procedures. This contravenes the current
official guidelines, namely that instruments used for treating such
patients should either be incinerated or undergo stringent decontam-
ination, the latter proving impossible in most dental practices because
of the lack of vacuum autoclaves. Many respondents commented on
the questionnaire that they would need to seek advice. It is important
that dentists are aware of how to access appropriate expertise and full
details are given in the Department of Health publication
‘Creutzfeldt-Jakob Disease: Guidance for Healthcare Workers’.
The prion problem is a significant potential complication for
infection control policy making in dentistry. There are still many
unknowns in the equation, particularly the level of prion infectivity
(if any) in human oral and dental tissues. The more widespread tis-
sue distribution of vCJD compared with the classic forms15 is a con-
cern and work is urgently needed to examine oral tissues for the
agent of vCJD. There are no questions which can be asked in the
medical history that will identify those infected with vCJD and pre-
sent knowledge does not indicate whether the number of such
patients is small, or runs into thousands. Until further information
Fig. 3 The frequency of updating of dental patients’ medical histories
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becomes available, dentists, along with all other healthcare workers,
must ensure that they are applying the principles of universal infec-
tion control rigorously and, in particular, that instrument cleaning
prior to sterilisation is undertaken thoroughly.
The authors would like to thank all those dental surgeons who kindly completed
and returned the questionnaire.
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